"Somos una institución de investigación, desarrollo tecnológico e innovación que dirige sus esfuerzos en dos líneas: Biotecnología y salud y Agua, suelo y sociedad. Somos un centro de investigación interdisciplinario, en el que colaboran el Estado peruano, la Universidad Nacional Mayor de San Marcos, centros de investigación navionales e innovadores, con la finalidad de mejorar la competitividad del país en materia de medio ambiente y salud."

During the past decade, CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "HIV Prevention Trials Network" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "ViiV Healthcare" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS" are "HIV Infections" (2 trials), "COVID-19" (1 trials), "Healthy" (1 trials), "Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol" (1 trials) and "SARS-CoV-2" (1 trials). Many other conditions were trialed in "CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS" in a lesser frequency.

Most popular intervention types in "CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS" are "Biological" (3 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Ad26.COV2.S" (1 trials), "Ad26.Mos4.HIV" (1 trials), "CAB LA" (1 trials) and "Cabotegravir Oral Tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".